| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenues | $6.22B-2.9% | $6.40B+2.2% | $6.26B+1.4% | $6.17B-2.1% | $6.30B-3.5% | $6.53B-16.0% | $7.78B |
| Cost of sales | $2.90B+8.0% | $2.69B+6.9% | $2.52B+9.6% | $2.29B-3.7% | $2.38B+12.4% | $2.12B-6.8% | $2.27B |
| Gross profit | $3.31B-10.8% | $3.71B-0.9% | $3.75B-3.4% | $3.88B | — | — | — |
| Selling, general and administrative | $1.72B-2.2% | $1.76B-7.0% | $1.89B+11.1% | $1.70B+2.2% | $1.67B+23.0% | $1.36B-6.0% | $1.44B |
| Research and development | $366.0M-22.0% | $469.0M-11.2% | $528.0M+12.1% | $471.0M+38.9% | $339.0M+61.4% | $210.0M-4.5% | $220.0M |
| Acquired in-process research and development and milestones | $6.0M-92.6% | $81.0M+912.5% | $8.0M-92.5% | $107.0M+2.9% | $104.0M | $0 | — |
| Goodwill impairment | $301.0M | $0 | $0 | — | — | — | — |
| Restructuring costs | $95.0M+206.5% | $31.0M-50.0% | $62.0M+121.4% | $28.0M+833.3% | $3.0M-95.0% | $60.0M-23.1% | $78.0M |
| Interest expense | $504.0M-3.1% | $520.0M-1.3% | $527.0M+24.9% | $422.0M+63.6% | $258.0M | $0 | — |
| Exchange losses | $14.0M-46.2% | $26.0M-38.1% | $42.0M+281.8% | $11.0M+175.0% | $4.0M-90.9% | $44.0M | — |
| Other (income) expense, net | -$119.0M-666.7% | $21.0M+40.0% | $15.0M+0.0% | $15.0M-11.8% | $17.0M+288.9% | -$9.0M-113.6% | $66.0M |
| Income before income taxes | $425.0M-47.3% | $807.0M+19.9% | $673.0M-40.0% | $1.12B-26.6% | $1.53B-44.4% | $2.75B-25.5% | $3.70B |
| Income tax expense (benefit) | $238.0M+517.5% | -$57.0M+83.7% | -$350.0M-270.7% | $205.0M+15.2% | $178.0M-64.1% | $496.0M+27.2% | $390.0M |
| Net income | $187.0M-78.4% | $864.0M-15.5% | $1.02B+11.6% | $917.0M-32.1% | $1.35B-37.5% | $2.16B-32.9% | $3.22B |
| Basic (in dollars per share) | $720000.00-78.6% | $3360000.00-16.2% | $4010000.00+11.1% | $3610000.00-32.3% | $5330000.00+62558585.4% | $8.52-32.9% | $12.69 |
| Diluted (in dollars per share) | $720000.00-78.4% | $3330000.00-16.5% | $3990000.00+11.1% | $3590000.00-32.4% | $5310000.00+62323843.7% | $8.52-32.9% | $12.69 |
| Basic (in shares) | 259.50B+1.0% | 257.05B+0.7% | 255.24B+0.5% | 254.08B+0.2% | 253.54B+99908.7% | 253.5M-100.0% | 253.52T |
| Diluted (in shares) | 260.76B+0.6% | 259.15B+1.1% | 256.27B+0.4% | 255.17B+0.4% | 254.19B+100167.0% | 253.5M-100.0% | 253.52T |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.